Analytical Data
-
基因名
EIF4A1
- Application
-
别名
DDX2A; EIF-4A; EIF4A; ATP-dependent RNA helicase eIF4A-1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
P60842
-
表达区间
Met1~Thr271
-
分子量
35kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
EIF4A1, a member of the eukaryotic translation initiation factor family, is a crucial RNA helicase that plays a key role in the initiation of protein synthesis. It unwinds mRNA secondary structures, promoting the formation of the translation initiation complex and ensuring the proper assembly of ribosomes. Abnormalities in EIF4A1 function have been linked to various diseases, including cancer, neurodegenerative disorders, and viral infections, as these conditions often exploit the host's translational machinery for their own replication and survival. The study of recombinant EIF4A1 proteins provides insights into their enzymatic functions, structural properties, and interactions with other translation factors and RNA molecules. Such research is essential for developing targeted therapeutic strategies, as inhibiting or modulating EIF4A1 activity could potentially disrupt the protein synthesis pathways exploited by pathogenic organisms or malignant cells. Furthermore, understanding the molecular mechanisms governing EIF4A1's role in translation can contribute to the broader field of gene expression regulation and may unveil novel biological processes critical for cellular homeostasis. Overall, investigations into EIF4A1 recombinant proteins serve as a foundation for advancing our knowledge of translation regulation and its implications in health and disease.












